Natco Pharma Ltd 524816

Morningstar Rating
₹817.00 −4.50 (0.55%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

524816 is trading at a LOCK|yL$Y^ premium.
Price
₹821.50
Fair Value
LOCK|H.G@B^j$@
Uncertainty
LOCK|kP
1-Star Price
LOCK|h.#NB<Y
5-Star Price
LOCK|<.^TP@&%
Economic Moat
LOCK|Ss
Capital Allocation
—

Trading Information

Previous Close Price
₹821.50
Day Range
₹807.45–831.00
52-Week Range
₹774.00–1,226.10
Bid/Ask
₹0.00 / ₹0.00
Shares Outstanding
196.17M
Market Cap
₹160.27B
Volume/Avg
63,286 / 52,556

Key Statistics

Price/Earnings (Normalized)
18.04
Price/Sales
4.80
Dividend Yield (Trailing)
0.70%
Dividend Yield (Forward)
0.70%
Dividend Payment Schedule
Feb, Aug, Nov
Total Yield
0.70%

Company Profile

Natco Pharma Ltd is engaged in the development, manufacturing, and marketing of Finished Dosage Formulations (FDFs), Active Pharmaceutical Ingredients (APIs), and Agrochemicals. The Group's API business develops cGMP-compliant drug substances, with oncology as its core therapeutic area, along with CNS, pain management, and cardiovascular care. The FDFs portfolio comprises products across neurology, oncology, hepatology, infectious diseases, cardiology, and other areas, and the Agrochemicals business offers insecticides, fungicides, plant growth promoters, herbicides, and other related products. Its reportable segments are Pharmaceuticals, which derives key revenue, and Agro Chemicals. Geographically, the Group derives maximum revenue from the USA, and the rest from India and other markets.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Mid Core
Total Number of Employees
5,060

Valuation

Metric
524816
Price/Earnings (Normalized)
18.04
Price/Book Value
1.66
Price/Sales
4.80
Price/Cash Flow
29.44
Price/Earnings
524816

Financial Strength

Metric
524816
Quick Ratio
1.43
Current Ratio
2.17
Interest Coverage
15.39
Quick Ratio
524816

Profitability

Metric
524816
Return on Assets (Normalized)
7.43%
Return on Equity (Normalized)
8.96%
Return on Invested Capital (Normalized)
8.82%
Return on Assets
524816

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
LOCK|>nTvW<W<LOCK|?@d&?$71B
Teva Pharmaceutical Industries Ltd
TEVA
LOCK|%&pPz<LLOCK|zZsx$47B
Haleon PLC ADR
HLN
LOCK|?<DjL$LOCK|^$$$39B
Zoetis Inc Class A
ZTS
LOCK|Ln#VN!jLOCK|jM<$33B
Viatris Inc
VTRS
LOCK|kwC$%PjLOCK|!%B$23B
Elanco Animal Health Inc
ELAN
LOCK|J$rLOCK|%#$13B
Dr Reddy's Laboratories Ltd ADR
RDY
LOCK|F^z<h$$LOCK|L#$12B
Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
LOCK|V%GFT^vLOCK|grD$4B
Prestige Consumer Healthcare Inc
PBH
LOCK|%CT>l?bLOCK|T@s%$2B
Perrigo Co PLC
PRGO
LOCK|xFm><^LOCK|vr$2B

Sponsor Center